|

Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart Disease

RECRUITINGSponsored by Leiden University Medical Center
Actively Recruiting
SponsorLeiden University Medical Center
Started2014-01-01
Est. completion2028-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06969924

Summary

This study aims to evaluate the real-world effects of cardiac resynchronization therapy (CRT) in adult patients with congenital heart disease (ACHD). Specifically, it seeks to determine whether CRT improves clinical outcomes in this unique patient population and to identify factors associated with a favorable response to therapy.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* ACHD patients who underwent CRT implantation

Exclusion Criteria:

* Less than 18 years old on the moment of CRT implantation
* Patient objection to the use of retrospective data

Conditions2

Adult Congenital Heart DiseaseHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.